
Stage: Revenue generating
Number of employees: 1-5
Funding history:
DDC is a healthcare company focused on the development and commercialization of innovative therapies for diabetes and obesity deploying digital therapeutics and data analytics based proprietary platform.
DDC is a healthcare company focused on the development and commercialization of innovative therapies for diabetes and obesity deploying digital therapeutics and data analytics based proprietary platform.
Our mission is to deploy modern technology to regulate, high blood sugar by slowly replacing the patient’s medicinal intake with life style based integrated care that prevents long term side effects.
DDC will have two part approach:
1. Diabetic Coach - http://www.drinet.com/diabetescoach1.asp
2. Diabetic Machine - http://www.drinet.com/ddm.asp
Dedicated Diabetic Machine (DDM)
Digital Solution for High Blood Sugar
DDM is a non-pharmaceutical tool, resembles an exercise machine, and is designed for diabetes wellness. It converges digital therapeutics and telehealth with real time data analytics to activate body's own immunity by repairing impaired cells and facilitating nutrient absorption. It is a safe, portable, cost effective and non-invasive device for home use. It will reduce dependence on modern medicine, their side effects, complications, and can be a significant help to diabetics worldwide.
DDC activates the body’s own immunity to regulate
hormones responsible for blood sugar metabolism, facilitate
nutrient absorption at a regular pace, and promote natural processes
Our business is based on four ideas:
Converge data, digital therapeutics and telehealth to reduce cost
Integrated diabetic management approach
Mind and emotions play a pivotal role in healthy living
Reduce dependence on modern medicine, their side effects, and complications
DDC does not have any direct competition for external, non-invasive, and therapeutic devices for high blood sugar.
The modern drugs and insulin does provide competition, however DDC addresses the needs of external therapies to counteract the long term dangerous side effects of these drugs.
Stem cells research and its implementation can provide competition in future.
Genome science and personalized medicine can also provide some competition in future.
GI Dynamics implants 5ft. long tube in the stomach surgically.
Entero-Medics Inc. develops implantable systems for the treatment of obesity.